Navigation Links
Breakthrough Announced in Development of Bird flu drug

A breakthrough in the development of a bird flu drug that could treat humans in the event of an outbreak has been announced by scientists.//

However they have warned that the final version of the drug to be used to treat the H5N1 virus would probably take another five years to be produced.

The 238 cases of human infection have all been from direct contact with infected birds. Scientists say that so far no evidence exists that the virus is mutating towards a state where it is transmissible among humans, although this could happen at any time.

About 60 percent of those infected with the deadly H5N1 virus have died. The best known drugs to fight the H5N1 infection in humans are zanamivir known as Relenza and oseltamivir commonly known as Tamiflu, both of which were originally developed to fight other forms of human flu.

Now lead scientist by John Skehel of London's National Institute of Medical Research and his team of researchers announced the finding of a cavity in the N1 or neuraminidase part of the H5N1 virus which could be exploited as a potential weak point in its destruction.

Mr Skehel said: "It is a race. You have got to try to keep ahead of variation and in the case of H5N1 particularly the emergence of transmission from human to human".
'"/>




Page: 1

Related medicine news :

1. Sperm washing helps couples – Breakthrough in focu
2. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
3. Breakthrough in eye treatment
4. Genetic Breakthrough in Common Eye Problem
5. Breakthrough in cancer therapy
6. Breakthrough in Type II Diabetes
7. Breakthrough In Stem Cell Work
8. A Likely Breakthrough For Prostate Cancer Patients
9. New DNA Breakthrough Can Change Future Of Medicine
10. Breakthrough In New Vaccine For Malaria
11. Medical Breakthrough - Kidney Transplant Recipient Survives Without Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Breakthrough Announced Development Bird flu drug

(Date:7/25/2014)... Hospital and MOSI officially announced a transformational partnership that will ... make a difference in the Tampa Bay community. Florida Hospital ... the support needed to keep the science center moving forward. ... Dome Theatre from film to a state-of-the-art digital 3D projection ... the state of Florida, and it is one of the ...
(Date:7/25/2014)... Diego, CA (PRWEB) July 25, 2014 AttorneyOne.com, ... all the latest information from the FDA on Ibuprofen ... July 21, that one lot of Ibuprofen and one lot ... recalled due to mislabeled packaging. Oxcarbazepine is used for ... epilepsy. , The reason for the recall is ...
(Date:7/25/2014)... July 25, 2014 A new study of ... of which are published today in Cancer , found ... and 74 who had an abnormal finding on a lung ... quality of life than did those who were screened and ... a surprise to the researchers. “We expected that participants with ...
(Date:7/25/2014)... 2014 This is a professional ... the Galactooligosaccharides (GOS) industry in Global and ... the industry, including definitions, applications and industry chain ... analysis are provided with a focus on history, ... A comparison between the international and Chinese situation ...
(Date:7/25/2014)... (HealthDay News) -- Shift workers, especially men, may be at ... on such schedules, a new study suggests. Also at ... set schedule, with shifts moving around at various times of ... said one expert, Dr. Alan Manevitz, a clinical psychiatrist at ... long known that working shifts disrupts many key body chemicals, ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 4Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 5Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 3Health News:Study Links Shift Work to Risk for Type 2 Diabetes 2Health News:Study Links Shift Work to Risk for Type 2 Diabetes 3
... Swanson got,leading scientists and researchers at the International ... natural rubber latex (NRL) yesterday,with insights into the ... Corporation. This commercially available NRL source,material has ultra ... desirable NRL properties in finished products., Vystar ...
... 2008 Elsevier and the Alzheimer,s ... Journal of the Alzheimer,s Association ( www.alzheimersanddementia.org ... MEDLINE (www.pubmed.gov) is the premier bibliographic database of ... the National Institutes of Health (NIH), MEDLINE contains ...
... Connecticut,Hospice, Inc., birthplace of Hospice in America, is ... from The Henrietta Szold-Hadassah-Hebrew,University School of Nursing, Jerusalem ... Nursing., Lauren Brown, MSN, Co-Director of Education, ... F. Pfriem International,Fellowship in Hospice and Palliative Nursing, ...
... the AHA-McKesson Quest for Quality Prize, ANN ARBOR, ... professionals of the University of Michigan Health,System provide some ... some of the safest, too. That,s according to the ... year,s lone finalist,for a major annual award., U-M ...
... HRC ) fiscal 2008 third quarter earnings release ... to participate in its,webcast the following morning on Thursday, ... Release: Hill-Rom Holdings, Inc.,s Fiscal 2008 Third Quarter,Earnings Release ... released to,the public after the NYSE close on Wednesday, ...
... Highlights:, - Record GAAP diluted EPS increased 34.2 percent to $0.51 from $0.38 in ... second-quarter 2007 - Record diluted EPS ... assets ... - Net revenues increased 15.6 percent to nearly $12.8 billion, - Specialty revenues ...
Cached Medicine News:Health News:Vytex(TM) Natural Rubber Latex Manufacturing Test Results Get International Latex Conference Buzzing 2Health News:Vytex(TM) Natural Rubber Latex Manufacturing Test Results Get International Latex Conference Buzzing 3Health News:Vytex(TM) Natural Rubber Latex Manufacturing Test Results Get International Latex Conference Buzzing 4Health News:Alzheimer's & Dementia: The Journal of the Alzheimer's Association accepted for coverage in MEDLINE 2Health News:U-M Health System Honored by American Hospital Association for High Quality Care and Patient Safety 2Health News:U-M Health System Honored by American Hospital Association for High Quality Care and Patient Safety 3Health News:U-M Health System Honored by American Hospital Association for High Quality Care and Patient Safety 4Health News:Hill-Rom Holdings, Inc. Invites You to Join its Fiscal 2008 Third Quarter Earnings Webcast 2Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 2Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 3Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 4Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 5Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 6Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 7Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 8Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 9Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 10Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 11Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 12Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 13Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 14Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 15Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 16Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 17Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 18Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 19Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 20Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 21Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 22Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 23Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 24Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 25Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 26Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 27Health News:Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance 28
(Date:7/25/2014)... July 25, 2014  Acsis Inc., the market ... serialization solutions, has recently posted an article, ... current and future needs for companies, extended supply ... supply chain model no longer work today.  The ... the growth of mobile technology, machine to machine ...
(Date:7/25/2014)... , N.Y. and MEXICO CITY , ... today announced that PLM, a Latin American healthcare sciences ... to deliver medical information on conditions such as cancer ... can now access the most up-to-date information to deliver ... medical professionals is growing rapidly, with many relying on ...
(Date:7/25/2014)...  AMETEK, Inc. (NYSE: AME ) today ... as Vice President and General Manager, Engineered Medical Components, ... "I am pleased that Kurt has joined ... experience, especially in the medical device industry, and we ... growth and success of our medical components businesses," commented ...
Breaking Medicine Technology:Acsis Addresses Questions on the Modern Supply Chain 2Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 2Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 3Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 4AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components 2
... July 22, and OSAKA, Japan, July 23 ... Takeda Global Research & Development Center, Inc., a wholly ... U.S. Food and Drug Administration (FDA) that the FDA ... for the fixed-dose combination (FDC) of alogliptin and ACTOS((R)) ...
... , MENLO PARK, Calif., July 22 Apieron, ... positive coverage policy for the measurement of exhaled nitric oxide ... peer-reviewed evidence is sufficient to support benefit coverage for the ... the measurement of exhaled nitric oxide is considered medically necessary ...
Cached Medicine Technology:Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) 2Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) 3CareFirst BCBS Covers eNO Measurement for Diagnosis, Asthma Treatment 2
Use the Mo Bio Vortex Adapter in conjunction with the Vortex Genie 2 for rapid bead beating procedures. Using the Mo Bio Vortex Adapter is an inexpensive alternative to other bead beating and Fast Pr...
... Combines BchiVac V-500, water-cooled secondary condenser ... housing Model V-500 is a powerful PTFE ... vacuum applications. Applications Ideally ... rotary evaporators Laboratory vacuum source ...
... secondary condenser to trap residual solvent vapors ... vacuum pump designed to handle most vacuum ... for use with up to two rotary ... instruments including vacuum ovens, concentrators, gel dryers, ...
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
Medicine Products: